Видео ютуба по тегу Finerenone

Finerenone in Heart Failure with Preserved Ejection Fraction | NEJM
Finerenone in Heart Failure with Preserved Ejection Fraction | NEJM
ESC 24: FINE-HEART: Finerenone in HF & CKD
ESC 24: FINE-HEART: Finerenone in HF & CKD
FIGARO: Where will finerenone fit into diabetic kidney disease treatment | David Wheeler
FIGARO: Where will finerenone fit into diabetic kidney disease treatment | David Wheeler
Finerenone Investor-Webinar
Finerenone Investor-Webinar
Finerenone per l'HFmrEF e HFpEF: i risultati del trial FINEARTS-HF
Finerenone per l'HFmrEF e HFpEF: i risultati del trial FINEARTS-HF
HFSA 24: Finerenone Across the Ejection Fraction Spectrum: FINEARTS-HF
HFSA 24: Finerenone Across the Ejection Fraction Spectrum: FINEARTS-HF
NEJM at ESC — Finerenone in Heart Failure for Mildly Reduced or Preserved Ejection Fraction
NEJM at ESC — Finerenone in Heart Failure for Mildly Reduced or Preserved Ejection Fraction
Discovery of Finerenone | Dr Lars Bärfacker (Bayer) | Society of Chemical Industry YCP/FCG Webinar
Discovery of Finerenone | Dr Lars Bärfacker (Bayer) | Society of Chemical Industry YCP/FCG Webinar
So, what is finerenone, anyway?
So, what is finerenone, anyway?
Finerenone... adding life to years in Kidney Disease
Finerenone... adding life to years in Kidney Disease
Time to Significant Benefit of Finerenone in Patients with Heart Failure | JACC | HFSA 2024
Time to Significant Benefit of Finerenone in Patients with Heart Failure | JACC | HFSA 2024
George Bakris, MD | Use of Finerenone in Patients with Diabetes Who Have Kidney Disease
George Bakris, MD | Use of Finerenone in Patients with Diabetes Who Have Kidney Disease
The Role of Novel Nonsteroidal Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease
The Role of Novel Nonsteroidal Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease
Simonetta Genovesi - Le nuove terapie delle malattie renali: Il Finerenone
Simonetta Genovesi - Le nuove terapie delle malattie renali: Il Finerenone
ESC 24 Hot Line Discussion: The FINEARTS-HF Trial
ESC 24 Hot Line Discussion: The FINEARTS-HF Trial
FIGARO-DKD Trial Results
FIGARO-DKD Trial Results
Mineralocorticoid Axis in Health and Disease- History, Evolution and Clinical Implications
Mineralocorticoid Axis in Health and Disease- History, Evolution and Clinical Implications
Effects of canagliflozin versus finerenone on cardiorenal outcomes
Effects of canagliflozin versus finerenone on cardiorenal outcomes
Medicines to help people with Chronic Kidney Disease - Finerenone | UHL NHS Trust
Medicines to help people with Chronic Kidney Disease - Finerenone | UHL NHS Trust
Finerenone in Patients With Recent Worsening Heart Failure Event: The FINEARTS-HF Trial | HFSA 2024
Finerenone in Patients With Recent Worsening Heart Failure Event: The FINEARTS-HF Trial | HFSA 2024